People: Vanessa Woolhead, Hannah Darcy, David Church

The Diabetic Remission Clinic Team in the Queen Mother Hospital for Animals in Hertfordshire is investigating the optimum methods to achieve good control, and ultimately diabetic remission, in diabetic pets. The Clinic provides dedicated care for diabetic cats while giving owners and vets the satisfaction of contributing to veterinary research and benefit of specialist advice on diabetic management.

A proportion of diabetic cats can enter a state of diabetic remission and no longer require insulin treatment. However, these cats can still have reduced pancreatic β-cell function and mass, and approximately 30% of them will experience a relapse of their diabetes and require insulin therapy to be reinstated. Drugs that can promote insulin secretion, and stimulate β-cell proliferation and survival might be beneficial in preventing relapse of diabetes in cats that are already in remission. With our current clinical trial, we aim to investigate the benefit of one such drug in cats that have recently entered diabetic remission (last insulin injection no longer than 4 months ago).  

Cats in remission will be eligible for a 2-year trial and will benefit from initial underlying disease assessment, monthly re-examinations at our dedicated diabetic remission clinic, free treatment with the trial drug and a year’s supply of high-protein, low-carbohydrate diet – all at no cost to owners! We hope that cat owners will appreciate the opportunity to participate in research that directly benefits their own pet while contributing to our knowledge of the optimum treatment for diabetic cats.  

For more information, or to discuss a potential case, please contact Katarina Hazuchova via the following:



Telephone: 01707 666 605

Fax: 01707 666223  

We have closed the recruitment for our clinical trial investigating the benefit of exenatide in increasing the rate of diabetic remission in diabetic cats. We are most grateful to all owners and cats who participated in our study, as well as all veterinary practices for their help with patient recruitment. This work would not have been possible without your contribution!

We will advertise our next project shortly on this website as well as on our dedicated Facebook page:

Please note that we are unable to offer the free IGF-1 service at this time. However, IGF-1 and fructosamine can now be measured at a competitive price either on their own or as a package at our laboratory using this form:

We would like to express our gratitude to all our colleagues in practice who have sent samples thus far for our studies. The IGF-1-project has led to major revelations including the rediscovery of acromegaly as underlying cause of feline diabetes and all clinicians submitting samples to this project should feel proud about their contribution.

Top of page